98-79-3
98-79-3
Chemical Structure
L-Pyroglutamic acid
- CAS No.: 98-79-3
- Formula:C5H7NO3
- Molecular Weight:129.11
IUPAC Name: (S)-5-oxopyrrolidine-2-carboxylic acid
InChIKey: ODHCTXKNWHHXJC-VKHMYHEASA-N
SMILES: O=C(O)[C@H](CC1)NC1=O
Biological Activity: L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid can be used as a biomarker for systemic lupus erythematosus (SLE)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Pyroglutamic acid | 98.57% | L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid can be used as a biomarker for systemic lupus erythematosus (SLE). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyroglutamic acid (Standard) | 99.77% | L-Pyroglutamic acid (Standard) is the analytical standard of L-Pyroglutamic acid (HY-76082). This product is intended for research and analytical applications. L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid standard can be used as a biomarker for systemic lupus erythematosus (SLE). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyroglutamic acid-13C5 | L-Pyroglutamic acid-13C5 is the 13C labeled L-Pyroglutamic acid (HY-76082). L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid can be used as a biomarker for systemic lupus erythematosus (SLE). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyroglutamic acid-d5 | 98.6% | L-Pyroglutamic acid-d5 is the deuterium labeled L-Pyroglutamic acid (HY-76082). L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levetiracetam-d6 (ring-d6) | 98.70% | Levetiracetam-d6 (ring-d6) can be used as internal standard for the determination of Levetiracetam (HY-B0106) content in whole blood. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl DL-pyroglutamate | 97.37% | Methyl DL-pyroglutamate is a kind of biochemical reagent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl L-pyroglutamate | 99.62% | Methyl L-pyroglutamate ((S)-Methyl 5-oxopyrrolidine-2-carboxylate) is a phenolic compound. Methyl L-pyroglutamate can be isolated from Portulaca oleracea L. Methyl L-pyroglutamate slightly inhibits NO production. Methyl L-pyroglutamate can be used in the research of inflammatory diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyroglutamic acid ethyl ester | L-Pyroglutamic acid ethyl ester (Compound 2c) is an intermediate. L-Pyroglutamic acid ethyl ester is involved in the synthesis of γ-aminobutyrate transaminase inactivators. L-Pyroglutamic acid ethyl ester can be used in epilepsy and Huntington's disease research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-Pyrrolidine-2-carboxylic acid-d3 | (R)-Pyrrolidine-2-carboxylic acid-d3 is the deuterium labeled (R)-pyrrolidine-2-carboxylic acid. (R)-pyrrolidine-2-carboxylic acid is an endogenous metabolite. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyroglutamic acid sodium | L-Pyroglutamic acid sodium is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid sodium is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid sodium can be used as a biomarker for systemic lupus erythematosus (SLE). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Piracetam-d8 | Piracetam-d8 (UCB-6215-d8) is the deuterium labeled Piracetam. Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Piracetam-d6 | Piracetam-d6 is deuterium labeled Piracetam. Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-5-Oxopyrrolidine-2-carboxylic acid (Standard) | ≥98% | (R)-5-Oxopyrrolidine-2-carboxylic acid (Standard) is the analytical standard of (R)-5-Oxopyrrolidine-2-carboxylic acid (HY-W002304). This product is intended for research and analytical applications. (R)-5-Oxopyrrolidine-2-carboxylic acid is a cyclic derivative of D-glutamate, as well as a heterocyclic structural unit and a precursor of cyclic imino acids. (R)-5-Oxopyrrolidine-2-carboxylic acid acts as an intermediate in the synthesis of dipeptide hybrids with antibacterial activity and the synthesis of Δ-1-pyrroline-5-carboxylic acid (P5C). (R)-5-Oxopyrrolidine-2-carboxylic acid is applicable to research related to organic synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Pyroglutamic acid | 98.0% | DL-Pyroglutamic acid (CAE) as an inactivator of hepatitis B surface, inactivates vaccinia virus, herpes simplex virus, and influenza virus except poliovirus. DL-Pyroglutamic acid is also a possible inhibitor of GABA transaminase, increases GABA amount with antiepileptic action. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Pyroglutamic acid-d5 | 99.21% | DL-Pyroglutamic acid-d5 is the deuterium labeled DL-Pyroglutamic acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Proline-d7 | 98.0% | DL-Proline-d7 is the deuterated-labeled DL-Proline (HY-W012908). DL-Proline is a racemic mixture of D-Proline and L-Proline, belonging to cyclic imino acids with a five-membered ring structure. DL-Proline serves as a key structural unit in peptide synthesis. DL-Proline stabilizes β-turn conformations and affects the secondary structure of peptide segments. DL-Proline exhibits biological activities such as regulating peptide segment conformations and enhancing cyclic peptide stability. DL-Proline can be used in research on diseases related to peptide structure and function, including cancer and bacterial infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Proline-d3 | 99.67% | DL-Proline-d3 is the deuterated-labeled DL-Proline (HY-W012908). DL-Proline is a racemic mixture of D-Proline and L-Proline, belonging to cyclic imino acids with a five-membered ring structure. DL-Proline serves as a key structural unit in peptide synthesis. DL-Proline stabilizes β-turn conformations and affects the secondary structure of peptide segments. DL-Proline exhibits biological activities such as regulating peptide segment conformations and enhancing cyclic peptide stability. DL-Proline can be used in research on diseases related to peptide structure and function, including cancer and bacterial infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Pyrohomoglutamic acid | 99.51% | L-Pyrohomoglutamic acid ((S)-2-piperidone-6-carboxylic acid) is a chiral δ-lactam formed via the cyclization of L-α-aminoadipic acid and can serve as an intermediate in research related to organic synthesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-6-Oxo-pipecolinic acid | 98.0% | D-6-Oxo-pipecolinic acid is the D-enantiomer of 6-Oxo-pipecolinic acid. 6-Oxo-pipecolinic acid is the biomarkers associated with pyridoxine-dependent epilepsy (PDE-ALDH7A1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Pyroaspartic acid | D-Pyroaspartic acid is a synthetic intermediate useful for pharmaceutical synthesis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Hydroxyproline-d4 | 99.85% | L-Hydroxyproline-d4 is deuterium labeled L-Hydroxyproline. L-Hydroxyproline, one of the hydroxyproline (Hyp) isomers, is a useful chiral building block in the production of many pharmaceuticals. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Proline-d3 | 99.84% | L-Proline-d3 is the deuterium labeled L-Proline. L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Proline-d7 | 99.93% | L-Proline-d7 is the deuterium labeled L-Proline. L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
